Tolvaptan use in severe neonatal autosomal dominant polycystic kidney disease (ADPKD): the pharmaceutical challenge
Tolvaptan use in severe neonatal autosomal dominant polycystic kidney disease (ADPKD): the pharmaceutical challenge
Unlicensed medications are used all the time in the management of diseases in childhood. Tolvaptan (Jinarc®) is a vasopressin V2-receptor antagonist licensed for use to slow the progression of cyst development and renal insufficiency of ADPKD in adults with CKD stage 1 to 3 with evidence of rapidly progressing disease. Studies of animal models implicate the antidiuretic hormone arginine vasopressin and its messenger cyclic adenosine monophosphate (cAMP) as promoters of kidney-cyst cell proliferation and luminal fluid secretion.
tolvaptan, polycystic kidney, adpkd, neonatal kidney
Olalekan, Kazeem
76a8cf63-1365-45b4-ad42-099d78e4bd85
Fox, Andy
39222d91-d4b5-42e8-b46b-4702340f0f9e
Gilbert, Rodney
2a1da00f-9bfc-4859-a473-41ca462019db
1 September 2016
Olalekan, Kazeem
76a8cf63-1365-45b4-ad42-099d78e4bd85
Fox, Andy
39222d91-d4b5-42e8-b46b-4702340f0f9e
Gilbert, Rodney
2a1da00f-9bfc-4859-a473-41ca462019db
Olalekan, Kazeem, Fox, Andy and Gilbert, Rodney
(2016)
Tolvaptan use in severe neonatal autosomal dominant polycystic kidney disease (ADPKD): the pharmaceutical challenge.
Archives of Disease in Childhood, 101 (e2).
(doi:10.1136/archdischild-2016-311535.61).
Record type:
Meeting abstract
Abstract
Unlicensed medications are used all the time in the management of diseases in childhood. Tolvaptan (Jinarc®) is a vasopressin V2-receptor antagonist licensed for use to slow the progression of cyst development and renal insufficiency of ADPKD in adults with CKD stage 1 to 3 with evidence of rapidly progressing disease. Studies of animal models implicate the antidiuretic hormone arginine vasopressin and its messenger cyclic adenosine monophosphate (cAMP) as promoters of kidney-cyst cell proliferation and luminal fluid secretion.
This record has no associated files available for download.
More information
e-pub ahead of print date: 17 August 2016
Published date: 1 September 2016
Keywords:
tolvaptan, polycystic kidney, adpkd, neonatal kidney
Identifiers
Local EPrints ID: 412978
URI: http://eprints.soton.ac.uk/id/eprint/412978
ISSN: 0003-9888
PURE UUID: 6a0f5a2f-2c50-4a5f-a6ef-686370ff1f9b
Catalogue record
Date deposited: 10 Aug 2017 16:30
Last modified: 15 Mar 2024 15:33
Export record
Altmetrics
Contributors
Author:
Kazeem Olalekan
Author:
Andy Fox
Author:
Rodney Gilbert
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics